A detailed history of Parisi Gray Wealth Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Parisi Gray Wealth Management holds 3,990 shares of NVO stock, worth $349,723. This represents 0.16% of its overall portfolio holdings.

Number of Shares
3,990
Previous 3,337 19.57%
Holding current value
$349,723
Previous $476,000 0.21%
% of portfolio
0.16%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$119.07 - $145.42 $77,752 - $94,959
653 Added 19.57%
3,990 $475,000
Q2 2024

Jul 15, 2024

BUY
$122.71 - $146.91 $71,908 - $86,089
586 Added 21.3%
3,337 $476,000
Q1 2024

Apr 15, 2024

BUY
$102.11 - $135.92 $280,904 - $373,915
2,751 New
2,751 $353,000
Q2 2019

Jul 19, 2019

SELL
$46.79 - $52.47 $10,106 - $11,333
-216 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$47.53 - $53.73 $10,266 - $11,605
216
216 $12,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Parisi Gray Wealth Management Portfolio

Follow Parisi Gray Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parisi Gray Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Parisi Gray Wealth Management with notifications on news.